Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)
Close on Nov 17, 2026Market cap $8.03BP/E –Yield –
Rhythm Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Rhythm Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$105.35M. For fiscal 2025 it was -$115.68M. The highest annual figure on record is -$6.98M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$115.68M | – |
| FY2024 | Dec 31, 2024 | -$113.88M | – |
| FY2023 | Dec 31, 2023 | -$136.16M | – |
| FY2022 | Dec 31, 2022 | -$173.43M | – |
| FY2021 | Dec 31, 2021 | -$146.00M | – |
| FY2020 | Dec 31, 2020 | -$121.98M | – |
| FY2019 | Dec 31, 2019 | -$122.75M | – |
| FY2018 | Dec 31, 2018 | -$62.06M | – |
| FY2017 | Dec 31, 2017 | -$29.46M | – |
| FY2016 | Dec 31, 2016 | -$23.22M | – |
| FY2015 | Dec 31, 2015 | -$6.98M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.15M | – |
| Q1 FY2026 | Mar 31, 2026 | -$44.19M | – |
| Q4 FY2025 | Dec 31, 2025 | -$25.39M | – |
| Q3 FY2025 | Sep 30, 2025 | -$26.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$40.35M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.85M | – |
| Q3 FY2024 | Sep 30, 2024 | -$25.22M | – |
| Q2 FY2024 | Jun 30, 2024 | -$29.08M | – |
| Q1 FY2024 | Mar 31, 2024 | -$40.74M | – |
| Q4 FY2023 | Dec 31, 2023 | -$29.38M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.25M | – |
| Q2 FY2023 | Jun 30, 2023 | -$41.09M | – |
| Q1 FY2023 | Mar 31, 2023 | -$36.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$46.99M | – |
| Q2 FY2022 | Jun 30, 2022 | -$38.81M | – |
| Q1 FY2022 | Mar 31, 2022 | -$53.63M | – |
| Q4 FY2021 | Dec 31, 2021 | -$40.47M | – |
| Q3 FY2021 | Sep 30, 2021 | -$40.16M | – |
| Q2 FY2021 | Jun 30, 2021 | -$31.84M | – |
| Q1 FY2021 | Mar 31, 2021 | -$33.53M | – |
| Q4 FY2020 | Dec 31, 2020 | -$29.12M | – |
| Q3 FY2020 | Sep 30, 2020 | -$27.03M | – |
| Q2 FY2020 | Jun 30, 2020 | -$29.73M | – |
| Q1 FY2020 | Mar 31, 2020 | -$36.10M | – |
| Q4 FY2019 | Dec 31, 2019 | -$32.22M | – |
| Q3 FY2019 | Sep 30, 2019 | -$33.61M | – |
| Q2 FY2019 | Jun 30, 2019 | -$25.55M | – |
| Q1 FY2019 | Mar 31, 2019 | -$31.38M | – |
| Q4 FY2018 | Dec 31, 2018 | -$20.98M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.94M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.48M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.65M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.89M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.14M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.02M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.18M | – |
See a number that looks wrong?